Related references
Note: Only part of the references are listed.Antithrombotic Effect of Antisense Factor XI Oligonucleotide Treatment in Primates
Jeffrey R. Crosby et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Bleeding and antidotes in new oral anticoagulants
Ammar Majeed et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2013)
Fibronectin coating of oxygenator membranes enhances endothelial cell attachment
Christian G. Cornelissen et al.
BIOMEDICAL ENGINEERING ONLINE (2013)
Continuous intravenous anaesthesia with sufentanil and midazolam in medetomidine premedicated New Zealand White rabbits
Patricia Hedenqvist et al.
BMC VETERINARY RESEARCH (2013)
Development of a Selective Peptide Macrocycle Inhibitor of Coagulation Factor XII toward the Generation of a Safe Antithrombotic Therapy
Vanessa Baeriswyl et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
A new phosphorylcholine-coated polymethylpentene oxygenator for extracorporeal membrane oxygenation: a preliminary experience
M. Pieri et al.
PERFUSION-UK (2013)
Activation of the Hemostatic System During Cardiopulmonary Bypass
Roman M. Sniecinski et al.
ANESTHESIA AND ANALGESIA (2011)
Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding
Alexey S. Revenko et al.
BLOOD (2011)
Factor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin
Joke Konings et al.
BLOOD (2011)
Mast Cells Increase Vascular Permeability by Heparin-Initiated Bradykinin Formation In Vivo
Chris Oschatz et al.
IMMUNITY (2011)
Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis
Ophira Salomon et al.
THROMBOSIS AND HAEMOSTASIS (2011)
A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo
Qiufang Cheng et al.
BLOOD (2010)
Hematopoietic and nonhematopoietic cell tissue factor activates the coagulation cascade in endotoxemic mice
Rafal Pawlinski et al.
BLOOD (2010)
Factor XII stimulates ERK1/2 and Akt through uPAR, integrins, and the EGFR to initiate angiogenesis
Gretchen A. LaRusch et al.
BLOOD (2010)
Polyphosphate modifies the fibrin network and down-regulates fibrinolysis by attenuating binding of tPA and plasminogen to fibrin
Nicola J. Mutch et al.
BLOOD (2010)
Factor XIIa Inhibitor Recombinant Human Albumin Infestin-4 Abolishes Occlusive Arterial Thrombus Formation Without Affecting Bleeding
Ina Hagedorn et al.
CIRCULATION (2010)
Update on Antithrombotic Therapy New Anticoagulants
John W. Eikelboom et al.
CIRCULATION (2010)
Inhibition of factor XI reduces thrombus formation in rabbit jugular vein under endothelial denudation and/or blood stasis
Misaki Takahashi et al.
THROMBOSIS RESEARCH (2010)
Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI
Erik I. Tucker et al.
BLOOD (2009)
Platelet Polyphosphates Are Proinflammatory and Procoagulant Mediators In Vivo
Felicitas Muller et al.
CELL (2009)
Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation
Yanming Wang et al.
JOURNAL OF CELL BIOLOGY (2009)
Ir-CPI, a coagulation contact phase inhibitor from the tick Ixodes ricinus, inhibits thrombus formation without impairing hemostasis
Yves Decrem et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Reduced incidence of ischemic stroke in patients with severe factor XI deficiency
Ophira Salomon et al.
BLOOD (2008)
Hemorrhagic complications of anticoagulant and thrombolytic treatment
Sam Schulman et al.
CHEST (2008)
Triggers, targets and treatments for thrombosis
Nigel Mackman
NATURE (2008)
Effect of varying nitric oxide release to prevent platelet consumption and preserve platelet function in an in vivo model of extracorporeal circulation
Amy M. Skrzypchak et al.
PERFUSION-UK (2007)
Factor XI contributes to thrombus propagation on injured neointima of the rabbit iliac artery
A. Yamashita et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis
C Kleinschnitz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Defective thrombus formation in mice lacking coagulation factor XII
T Renné et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
The impact of heparin-coated circuits on hemodynamics during and after cardiopulmonary bypass
R de Vroege et al.
ARTIFICIAL ORGANS (2005)
International union of pharmacology.: XLV.: Classification of the kinin receptor family:: from molecular mechanisms to pathophysiological consequences
LMF Leeb-Lundberg et al.
PHARMACOLOGICAL REVIEWS (2005)
Extracorporeal Life Support Registry Report 2004
SA Conrad et al.
ASAIO JOURNAL (2005)
The occasional venous thromboses seen in patients with severe (homozygous) FXII deficiency are probably due to associated risk factors: A study of prevalence in 21 patients and review of the literature
A Girolami et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2004)
Factor XII deficiency: a thrombophilic risk factor for retinal vein occlusion
C Kuhli et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2004)
Role of tissue factor in hemostasis, thrombosis, and vascular development
N Mackman
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Rapid generation of functional human IgG antibodies derived from Fab-on-phage display libraries
T Jostock et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2004)
Factor XI-dependence of surface- and tissue factor-initiated thrombus propagation in primates
A Gruber et al.
BLOOD (2003)
High molecular weight kininogen utilizes heparan sulfate proteoglycans for accumulation on endothelial cells
T Renné et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Reduced platelet activation and thrombosis in extracorporeal circuits coated with nitric oxide release polymers
GM Annich et al.
CRITICAL CARE MEDICINE (2000)